WP
RXDX

Woodline Partners’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Woodline Partners’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-317,113
Closed -$34M – 813
2023
Q1 		$34M Buy
317,113
+5,169
+2% +$595K 0.46% 59
2022
Q4 		$34.3M Buy
311,944
+34,207
+12% +$2.22M 0.46% 48
2022
Q3 		$16.4M Sell
277,737
-913,924
-77% -$41.8M 0.23% 130
2022
Q2 		$33.6M Buy
1,191,661
+741,403
+165% +$21.5M 0.52% 38
2022
Q1 		$17M Buy
450,258
+199,932
+80% +$7.9M 0.28% 114
2021
Q4 		$9.9M Buy
250,326
+42,789
+21% +$1.34M 0.14% 198
2021
Q3 		$4.92M Buy
207,537
+4,855
+2% +$115K 0.08% 253
2021
Q2 		$4.98M Sell
202,682
-7,642
-4% -$170K 0.09% 217
2021
Q1 		$3.84M Buy
+210,324
New +$4.34M 0.09% 218

Other funds holding RXDX

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
FCA
FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Woodline Partners's RXDX Position: Q2 2023 in Review

Woodline Partners sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 317,113 shares — an estimated $34M sold.

Woodline Partners first reported a position in RXDX in Q1 2021 and held it in 9 quarters. The position peaked at $34.3M in Q4 2022. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

  • Woodline Partners reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Woodline Partners sold 317,113 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $34M.
  • Woodline Partners first reported a position in Prometheus Biosciences, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
  • Woodline Partners's Prometheus Biosciences, Inc. Common Stock position peaked at $34.3M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Woodline Partners's 13F filing for Q2 2023, filed 14 Aug 2023.